- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT04702633
Immuno-molecular Approaches for Non-invasive Diagnosis of Prostate Cancer (PROSTA-PAP)
Non-invasive Isolation and Characterization of Prostate Tumor Cells for Prostate Cancer Diagnosis
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Prostate cancer is one of the most frequently diagnosed cancers and a leading cause of cancer death in men worldwide. Existing methods of diagnosis and monitoring of prostate cancer are inadequate due to their invasiveness, inaccuracy, cost, access uneven, etc., making difficult the diagnosis and patient's follow up. New techniques and methods are necessary to improve diagnosis.
Biological liquids might represent an attractive target to isolate prostate tumour cells for these purposes. In recent years, several studies have been carried out with the aim of reducing and / or avoiding the limits of sensitivity and specificity of current methods of screening for prostate cancer and thus obtain new biomarkers for the diagnosis and / or non-invasive monitoring.
However, due to technical and technological difficulties few studies have been performed to investigate the non-invasive isolation and direct analysis of tumour cells. Our project is therefore an innovative project which aims to study a new approach for the early diagnosis of prostate cancer, with better sensitivity and specificity.
Undersøgelsestype
Tilmelding (Forventet)
Kontakter og lokationer
Studiekontakt
- Navn: Marie Benhammani-Godard
- Telefonnummer: 0033158411190
- E-mail: marie.godard@aphp.fr
Undersøgelse Kontakt Backup
- Navn: Julien ANRACT, MD
- Telefonnummer: + 33(0)1 58 41 33 55
- E-mail: julien.anract@aphp.fr
Studiesteder
-
-
-
Paris, Frankrig, 75014
- Rekruttering
- Cochin Hospital
-
Kontakt:
- Julien ANRACT, MD
- Telefonnummer: + 33(0)1 58 41 33 55
- E-mail: julien.anract@aphp.fr
-
Kontakt:
- Laura Nalleli GARRIDO CASTILLO, MSc
- Telefonnummer: 00 33 1 40 61 56 06
- E-mail: laura.garrido@rarecells.com
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
- Barn
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Beskrivelse
Inclusion Criteria:
- Patients with a diagnosis of localized or metastatic prostate cancer.
- No prior or other oncological treatment.
- Patients undergoing prostate biopsy in the context of prostate cancer diagnosis.
- Patients with an elevation of PSA (Prostate Specific Antigen), an abnormality on the rectal examination and / or an MRI signal motivating a prostate biopsy,
- Patients informed and not opposed to participating in the research
Exclusion Criteria:
- Patients not affiliated with French social security.
- Patients unable to understand the protocol.
- Patients diagnosed with another type of cancer within the past 5 years.
- Patients prostatectomized and/or treated for prostate cancer.
- Patients who wear a bladder catheter
- Patients under guardianship or curatorship
- Patients under AME
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Kohorter og interventioner
Gruppe / kohorte |
Intervention / Behandling |
---|---|
Confirmed diagnosis group
Patients with a diagnosis of prostate cancer (metastatic or advanced) before prostatectomy.
|
Kliniske data
Results obtained by biopsy and MRI results.
|
Pre-diagnosis group
Patients undergoing prostate biopsy in the context of prostate cancer diagnosis: PSA increases, and / or abnormal digital rectal examination (DRE) and / or an MRI detected signal.
|
Kliniske data
Results obtained by biopsy and MRI results.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Presence and number of prostate tumour cells in biological samples
Tidsramme: One month after biopsy or until the histological diagnosis will be obtained
|
Cell enrichment will be carried out using the ISET® (Isolation by SizE of Tumor/Trophoblastic cells) technology.
Identification will be performed by different spectroscopic and/or immune-molecular and/or cytological approaches
|
One month after biopsy or until the histological diagnosis will be obtained
|
Samarbejdspartnere og efterforskere
Samarbejdspartnere
Efterforskere
- Studiestol: Patrizia PATERLINI-BRECHOT, MD, PhD, INSERM and Rarecells Diagnostics
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Forventet)
Studieafslutning (Forventet)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- APHP201309
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Kliniske data
-
National Institute of Allergy and Infectious Diseases...Boston Children's Hospital; Benaroya Research InstituteAfsluttetSARS-CoV-2 | Coronavirus sygdom 2019 (COVID-19)Forenede Stater
-
Madigan Army Medical CenterTelemedicine & Advanced Technology Research Center; Analytics4Medicine,...UkendtUkontrolleret hypertensionForenede Stater
-
Mahidol UniversityUniversity of Medical Technology, YangonAfsluttetKognitiv forandringMyanmar
-
Thomas Jefferson UniversityAfsluttetHæmatopoietisk og lymfoid celle-neoplasma | Ondartet fast neoplasmaForenede Stater
-
BC Centre for Improved Cardiovascular HealthUniversity of British ColumbiaUkendt
-
University of MiamiRekruttering
-
Linkoeping UniversityAktiv, ikke rekrutterendeMyokardieinfarkt | SkrøbelighedSverige
-
University of SaskatchewanNovartis; Lung Association of SaskatchewanUkendtLungesygdom, kronisk obstruktivCanada
-
NuvoAir Medical PCRekrutteringKOL | Komorbiditeter og sameksisterende tilstandeForenede Stater
-
Aifred HealthMcGill UniversityAfsluttet